Surgical Outcomes After Fixation of Acromioclavicular Joint Dislocation with Hook Plate and Coracoacromial Ligament Transfer Technique.

Background: Treatment of acute and chronic acromioclavicular joint dislocations is still controversial. We aimed evaluation of surgical outcomes after using the combined technique with a hook plate and transposition of the coracoacromial ligament in the treatment of acromioclavicular dislocation.

Case Presentation: During two years 4 patients (2 acute and 2 chronic cases) were operated with this technique.

Arthroscopic Reduction and Percutaneous Osteosynthesis of Tibial Plateau Fractures.

Background: Tibial plateau fractures are complex lesions capable of causing severe consequences if not appropriately treated. They are often the result of high-energy trauma and, not rarely, are associated with significant soft-tissue and intra-articular injuries. Different therapeutic options can be managed in the treatment of these lesions.

Trio Clinical Exome Sequencing in a Patient With Multicentric Carpotarsal Osteolysis Syndrome: First Case Report in the Balkans.

Exome sequencing can interrogate thousands of genes simultaneously and it is becoming a first line diagnostic tool in genomic medicine. Herein, we applied trio clinical exome sequencing (CES) in a patient presenting with undiagnosed skeletal disorder, minor facial abnormalities, and kidney hypoplasia; her parents were asymptomatic. Testing the proband and her parents led to the identification of a mutation c.

Parosteal osteosarcoma.

In this retrospective clinical study, 6 cases of osteosarcoma of the bone have been analyzed. Five patients were with parosteal osteosarcoma and one with periosteal osteosarcoma. The study was performed at the Clinic for Orthopaedic Surgery in Skopje, Macedonia, from 1995 to 2005.

Limb-sparing in patients with non-metastatic high-grade osteosarcoma.

Purpose: To improve survival rates and functional outcome in patients with non-metastatic, high-grade osteosarcoma of the extremities, using the Scandinavian Sarcoma Group XIV neoadjuvant chemotherapy protocol.

Patients And Methods: The analysis included 37 patients treated during the period 2000-2005. Age range was 8 to 65 year (median 23).